Epidermolysis Bullosa: New Therapies Target Genetics and Wound Healing
Summary: This article reviews the latest therapeutic developments for epidermolysis bullosa (EB), a group of rare genetic disorders causing extremely fragile skin and chronic wounds. It highlights gene-targeted therapies, protein replacement approaches, and specialized wound care strategies designed to improve healing and quality of life.
Key Highlights:
- Genetic and molecular basis of different EB subtypes
- Promising new gene and cell-based therapies
- Advanced wound care tailored to EB patients
- Focus on reducing blistering, scarring, and complications
Keywords: epidermolysis bullosa, genetic wound disorders, EB wound care